You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

EVENTS

World Hemophilia Day 2021, Kedrion alongside patients

Today, more than ever, the company is close to those who are in a vulnerable condition

read more 

PLASMA & BIOTHERAPIES

Rh&Life, first subject included in the study

Two hundred pregnant women to be enrolled over five countries

read more 

PLASMA & BIOTHERAPIES

KIDCARES10, first patient enrolled in pediatric PI study

Thirty patients aged 2 to 17 years old to be enrolled over five European countries

read more 
  1. EVENTS - 17-04-2020

    World Hemophilia Day: socially distant but still united with patients

    Now more than ever, Kedrion is renewing its commitment to those who live with this rare disorder

    read more 
  2. EVENTS - 16-04-2020

    Kedrion supports live streaming of medical debate on the use of convalescent plasma to treat Covid-19

    Online roundtable “The Gift of the Cured versus the Pandemic” on air at DonatoriH24 on April 16

    read more 
  3. CORPORATE - 07-04-2020

    Coronavirus, from Plasma an anti Covid-19 treatment

    Kedrion’s commitment to find a treatment from convalescent patient plasma

    read more 

Pages

For more information please contact: [email protected]